Workforce challenges across Victorian medical oncology services.
health workforce
healthcare benchmarking
medical oncology
Journal
Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
26
08
2022
accepted:
13
12
2022
medline:
26
6
2023
pubmed:
27
12
2022
entrez:
26
12
2022
Statut:
ppublish
Résumé
Cancer incidence is growing, with increasing treatment options and durations. This has led to an increase workload on the current oncology workforce. The global pandemic has increased this pressure further. To determine the current medical oncology workforce in Victoria, current shortfalls and future anticipated shortfalls beyond the COVID-19 pandemic. A self-reported, cross-sectional observational study of all current adult Victorian cancer services in June 2020 examining workforce, workload and early effects of the COVID-19 pandemic. The current average workload of 242 new patients per full-time equivalent consultant in medical oncology across Victoria. This is higher than optimal to deliver a safe and efficient cancer service. The significant variation in workforce between sites highlights the areas in need of most urgent resource allocation. Use of safe prescribing practises such as electronic chemotherapy prescribing are not universal but urgently needed. The medical oncology workforce in Victoria is inadequate to meet current and future demands. This needs to be addressed urgently to avoid an adverse impact on cancer measures and quality standards. Better, standardised data collection is needed to allow for ongoing measures of workforce activity. Novel workforce solutions will also need to be implemented in the short and medium term in the face of global workforce shortages.
Sections du résumé
BACKGROUND
BACKGROUND
Cancer incidence is growing, with increasing treatment options and durations. This has led to an increase workload on the current oncology workforce. The global pandemic has increased this pressure further.
AIMS
OBJECTIVE
To determine the current medical oncology workforce in Victoria, current shortfalls and future anticipated shortfalls beyond the COVID-19 pandemic.
METHODS
METHODS
A self-reported, cross-sectional observational study of all current adult Victorian cancer services in June 2020 examining workforce, workload and early effects of the COVID-19 pandemic.
RESULTS
RESULTS
The current average workload of 242 new patients per full-time equivalent consultant in medical oncology across Victoria. This is higher than optimal to deliver a safe and efficient cancer service. The significant variation in workforce between sites highlights the areas in need of most urgent resource allocation. Use of safe prescribing practises such as electronic chemotherapy prescribing are not universal but urgently needed.
CONCLUSIONS
CONCLUSIONS
The medical oncology workforce in Victoria is inadequate to meet current and future demands. This needs to be addressed urgently to avoid an adverse impact on cancer measures and quality standards. Better, standardised data collection is needed to allow for ongoing measures of workforce activity. Novel workforce solutions will also need to be implemented in the short and medium term in the face of global workforce shortages.
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
946-950Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians.
Références
Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 2020; 21: 1023-34.
Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The impact of the COVID-19 pandemic on cancer care. Nat Cancer 2020; 1: 565-7.
Te Marvelde L, Wolfe R, McArthur G et al. Decline in cancer pathology notifications during the 2020 COVID-19-related restrictions in Victoria. Med J Aust 2021; 214: 281-3.
Wilson BE, Jacob S, Yap ML, Ferlay J, Bray F, Barton MB. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study. Lancet Oncol 2019; 20: 769-80.
Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC et al. Colorectal cancer statistics, 2020. CA Cancer J Clin 2020; 70: 145-64.
Bhimani J, Philipps L, Simpson L, Lythgoe M, Soultati A, Webb A et al. The impact of new cancer drug therapies on site specialised cancer treatment activity in a UK cancer network 2014-2018. J Oncol Pharm Pract 2020; 26: 93-8.
Victorian Cancer Registry. Cancer in Victoria: Statistics & Trends 2019. Melbourne, Victoria, Cancer Council Victoria, 2020.
Shanafelt TD, Gradishar WJ, Kosty M, Satele D, Chew H, Horn L et al. Burnout and career satisfaction among US oncologists. J Clin Oncol 2014; 32: 678-86.
de Azambuja E, Ameye L, Paesmans M, Zielinski CC, Piccart-Gebhart M, Preusser M. The landscape of medical oncology in Europe by 2020. Ann Oncol 2014; 25: 525-8.
Yang W, Williams JH, Hogan PF, Bruinooge SS, Rodriguez GI, Kosty MP et al. Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage. J Oncol Pract 2014; 10: 39-45.
Blinman PL, Grimison P, Barton MB, Crossing S, Walpole ET, Wong N et al. The shortage of medical oncologists: the Australian Medical Oncologist Workforce Study. Med J Aust 2012; 196: 58-61.
Bidwell S, Simpson A, Sullivan R, Robinson B, Thomas W, Jackson C et al. A workforce survey of New Zealand medical oncologists. N Z Med J 2013; 126: 45-53.
Fundytus A, Hopman WM, Hammad N et al. Medical oncology workload in Canada: infrastructure, supports, and delivery of clinical care. Curr Oncol 2018; 25: 206-12.
VCCN. Victorian COVID-19 Cancer Network, 2020.
Underhill C, Parente P, McArthur G, Haydon A, McLachlan SA, Wong ZW et al. Towards new models of cancer care in Australia: lessons from Victoria's response to the COVID-19 pandemic. Intern Med J 2020; 50: 1282-5.
Australian Bureau of Statistics: Australian Statistical Geography Standard (ASGS). Remoteness Structure, 2013.
Cancer Care Ontario. The Systemic Therapy Task Force Report, 2000.
Seruga B, Sullivan R, Fundytus A et al. Medical oncology workload in Europe: One continent, several worlds. Clin Oncol 2020; 32: e19-26.
Cashman H, Mayson E, Kliman D, Kesby J, Bell J, Vachalec S et al. Integrated electronic health record facilitates a safer and more efficient rural outreach haematology service. Intern Med J 2021; 51: 1869-75.
Huertas Fernandez MJ, Baena-Canada JM, Martinez Bautista MJ et al. Impact of computerised chemotherapy prescriptions on the prevention of medication errors. Clin Transl Oncol 2006; 8: 821-5.
Alotaibi T, Al Anizi CA. The impact of advanced nurse practitioner (ANP) role on adult patients with cancer: a quantitative systematic review. Appl Nurs Res 2020; 56: 151370.
Lwin Z, Broom A, Sibbritt D, Francis K, Karapetis CS, Karikios D et al. The Australian medical oncologist workforce survey: the profile and challenges of medical oncology. Semin Oncol 2018; 45: 284-90.
Adams C, Torode J, Henshall S, Cazap E, Ryel AL, Grey N. The World Cancer Declaration: from resolution to action. Lancet Oncol 2011; 12: 1091-2.
Australian Institute of Health Welfare. Deaths in Australia. AIHW: Canberra; 2021.